Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proctocolectomy, Restorative | 6 | 2021 | 190 | 1.620 |
Why?
|
| Colorectal Surgery | 3 | 2021 | 122 | 1.390 |
Why?
|
| Laparoscopy | 5 | 2023 | 2035 | 0.980 |
Why?
|
| Rectal Neoplasms | 6 | 2023 | 1157 | 0.970 |
Why?
|
| Colitis, Ulcerative | 11 | 2023 | 1922 | 0.900 |
Why?
|
| Nerve Block | 2 | 2020 | 704 | 0.850 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 1736 | 0.660 |
Why?
|
| Colonic Pouches | 4 | 2021 | 122 | 0.620 |
Why?
|
| Rectum | 5 | 2020 | 892 | 0.620 |
Why?
|
| Bibliometrics | 1 | 2021 | 350 | 0.570 |
Why?
|
| Colonic Neoplasms | 4 | 2023 | 2529 | 0.530 |
Why?
|
| Perineum | 1 | 2017 | 208 | 0.520 |
Why?
|
| Neoadjuvant Therapy | 3 | 2023 | 2821 | 0.510 |
Why?
|
| Colectomy | 10 | 2023 | 687 | 0.460 |
Why?
|
| Abdomen | 1 | 2020 | 1127 | 0.460 |
Why?
|
| Ileostomy | 3 | 2019 | 121 | 0.330 |
Why?
|
| Postoperative Complications | 15 | 2023 | 15627 | 0.330 |
Why?
|
| Abdominal Muscles | 2 | 2020 | 168 | 0.320 |
Why?
|
| Fecal Incontinence | 3 | 2024 | 241 | 0.260 |
Why?
|
| Crohn Disease | 3 | 2022 | 2278 | 0.250 |
Why?
|
| Biomedical Research | 1 | 2021 | 3421 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 9267 | 0.250 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2021 | 573 | 0.240 |
Why?
|
| Rectal Prolapse | 1 | 2024 | 33 | 0.220 |
Why?
|
| Hypoalbuminemia | 1 | 2023 | 86 | 0.210 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 2272 | 0.210 |
Why?
|
| Neoplasm Staging | 5 | 2023 | 11096 | 0.200 |
Why?
|
| Colitis | 1 | 2010 | 1230 | 0.200 |
Why?
|
| Linear Models | 2 | 2022 | 5865 | 0.190 |
Why?
|
| Diverticulitis, Colonic | 1 | 2022 | 138 | 0.180 |
Why?
|
| Anus, Imperforate | 1 | 2020 | 63 | 0.180 |
Why?
|
| Rectal Diseases | 1 | 2021 | 143 | 0.180 |
Why?
|
| Colonic Diseases | 1 | 2021 | 201 | 0.170 |
Why?
|
| Venous Thromboembolism | 2 | 2022 | 1863 | 0.160 |
Why?
|
| Rectal Fistula | 1 | 2019 | 75 | 0.160 |
Why?
|
| Retrospective Studies | 17 | 2023 | 80430 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 2419 | 0.140 |
Why?
|
| Surgical Stapling | 1 | 2017 | 98 | 0.140 |
Why?
|
| Anastomosis, Surgical | 2 | 2017 | 983 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2023 | 1165 | 0.140 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2018 | 154 | 0.130 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 6894 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 1 | 2023 | 1051 | 0.130 |
Why?
|
| Humans | 37 | 2024 | 760437 | 0.120 |
Why?
|
| Morphine | 1 | 2019 | 655 | 0.120 |
Why?
|
| Urinary Retention | 1 | 2015 | 106 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2020 | 642 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2024 | 64591 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2019 | 908 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2022 | 3512 | 0.110 |
Why?
|
| Colonoscopy | 3 | 2022 | 1392 | 0.110 |
Why?
|
| Cysts | 1 | 2018 | 681 | 0.110 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 1525 | 0.100 |
Why?
|
| Length of Stay | 3 | 2021 | 6413 | 0.100 |
Why?
|
| Demography | 1 | 2017 | 1648 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2021 | 2242 | 0.100 |
Why?
|
| Adenoma | 1 | 2022 | 2157 | 0.100 |
Why?
|
| Consensus | 1 | 2021 | 3115 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1494 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2022 | 12054 | 0.090 |
Why?
|
| Middle Aged | 13 | 2022 | 220382 | 0.090 |
Why?
|
| Male | 17 | 2023 | 360035 | 0.090 |
Why?
|
| Aged | 11 | 2024 | 168840 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 1540 | 0.080 |
Why?
|
| Defecation | 2 | 2021 | 190 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2023 | 3798 | 0.080 |
Why?
|
| Hospitals | 1 | 2021 | 3873 | 0.070 |
Why?
|
| Adult | 14 | 2024 | 220781 | 0.070 |
Why?
|
| ras Proteins | 1 | 2013 | 1052 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2021 | 835 | 0.070 |
Why?
|
| Female | 14 | 2022 | 391875 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9410 | 0.060 |
Why?
|
| Focus Groups | 2 | 2021 | 1404 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2015 | 1973 | 0.060 |
Why?
|
| Interdisciplinary Communication | 2 | 2021 | 931 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2019 | 3249 | 0.060 |
Why?
|
| Syndrome | 2 | 2021 | 3267 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4108 | 0.060 |
Why?
|
| Risk Factors | 5 | 2024 | 74055 | 0.060 |
Why?
|
| Colon | 2 | 2022 | 1791 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 1116 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10180 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2023 | 7948 | 0.050 |
Why?
|
| Pelvis | 2 | 2018 | 732 | 0.050 |
Why?
|
| Colon, Sigmoid | 1 | 2022 | 124 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7860 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 4509 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2022 | 23953 | 0.040 |
Why?
|
| Colostomy | 1 | 2020 | 105 | 0.040 |
Why?
|
| Ileum | 1 | 2022 | 557 | 0.040 |
Why?
|
| Industry | 1 | 2022 | 364 | 0.040 |
Why?
|
| Accreditation | 1 | 2023 | 473 | 0.040 |
Why?
|
| Ileus | 1 | 2019 | 66 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 58859 | 0.040 |
Why?
|
| Constipation | 1 | 2024 | 562 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2019 | 140 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13616 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 304 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 2018 | 42 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 54339 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2022 | 510 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2022 | 2852 | 0.030 |
Why?
|
| Conflict of Interest | 1 | 2022 | 554 | 0.030 |
Why?
|
| Laparotomy | 1 | 2018 | 457 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 432 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 36362 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12969 | 0.030 |
Why?
|
| Patients | 1 | 2020 | 905 | 0.030 |
Why?
|
| Time Factors | 3 | 2021 | 39947 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 1205 | 0.030 |
Why?
|
| Patient Participation | 1 | 2021 | 1442 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2013 | 302 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6340 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 2082 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2021 | 2975 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2021 | 2689 | 0.020 |
Why?
|
| Steroids | 1 | 2015 | 928 | 0.020 |
Why?
|
| Recurrence | 1 | 2022 | 8466 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1297 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2021 | 2517 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 1995 | 784 | 0.020 |
Why?
|
| Mental Health | 1 | 2024 | 3241 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2015 | 2642 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2897 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2015 | 1034 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20551 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9605 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4806 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1741 | 0.020 |
Why?
|
| Medicare | 1 | 2022 | 6732 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15820 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9639 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18379 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 1995 | 2331 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20078 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26063 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22097 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13338 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41366 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10698 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 5292 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14661 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81402 | 0.010 |
Why?
|
| Thyroglobulin | 1 | 1995 | 111 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72202 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1033 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 168253 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1995 | 907 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 8522 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 39078 | 0.000 |
Why?
|
| Child | 1 | 1995 | 80086 | 0.000 |
Why?
|
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_